Norway· NO-ID_50D1DE58-FCA4-465E-A104-2D63CD23FD9A
Nitazoxanide rising
A nitazoxanide product containing nitazoksanid, registered in Norway by Rising Pharmaceuticals. The same ATC class is registered in 3 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Nitazoxanide is registered in 3 of 19 countries.
Countries holding a registration under ATC P01AX11 (nitazoxanide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 2 of them publish a price we can compare per daily dose
Nitazoxanide · ATC P01AX11
3 / 19 countries
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Nitazoksanid
- Manufacturer
- Rising Pharmaceuticals
- Country
- Norway (NO)
- ATC code
- P01AX11
- ATC class
- Nitazoxanide
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
- no_merkevare_idID_50D1DE58-FCA4-465E-A104-2D63CD23FD9A
- no_varenummer3486256
- gtin364980526609
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
27 interactions on record for nitazoxanide.
Graded by severity as the source publishes them — 27 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nitazoxanide · interactions on record
27 records
- 27 moderate
Most severe, free to view
- GlibenclamideA10BB01moderate
- ChlorpropamideA10BB02moderate
- TolbutamideA10BB03moderate
- TolazamideA10BB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nitazoxanide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/042b8395-f5e6-42c0-98d4-574b761000d9 GET /v1/drugs/042b8395-f5e6-42c0-98d4-574b761000d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Nitazoksanid",
"merkevare_id": "ID_50D1DE58-FCA4-465E-A104-2D63CD23FD9A",
"name_form_strength": "Nitazoxanide rising tab 500 mg",
"prescription_group": "C"
}See everything about nitazoxanide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.